Clinical Trial for Alcohol Use Disorder and Post Traumatic Stress Disorder (PTSD)
Status:
Active, not recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
This is a randomized controlled Phase II clinical trial designed to evaluate the effects of
N-acetylcysteine (NAC) in reducing Alcohol Use Disorder (AUD) severity and Post Traumatic
Stress Disorder (PTSD) symptomatology among individuals with current AUD and PTSD.
Phase:
Phase 2
Details
Lead Sponsor:
Medical University of South Carolina
Collaborators:
National Institute on Alcohol Abuse and Alcoholism (NIAAA) National Institutes of Health (NIH)